Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae421 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Andreas H Lange und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark. Hauptthemen laut MEDLINE: Gallbladder, Glucagon-Like Peptide 2, Cholecystokinin, Gallbladder Emptying. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Hørslev-fonden, Savværksejer Jeppe Juhl og hustru Ovita Juhls Mindelegat, Novo Nordisk Foundation.
Abstract (Originalsprache)
Background and Objective Studies in humans and mice have demonstrated that the gut hormone glucagon-like peptide 2 (GLP-2) promotes gallbladder relaxation and refilling. Here, we assessed the effect of exogenous GLP-2 on gallbladder motility in the fasted state of healthy men with and without infusion of the potent gallbladder-contracting hormone cholecystokinin (CCK).
Methods
In a randomized, double-blind, placebo-controlled, crossover study, 15 male participants (mean [SD]: age 24.7 [3.6] years; body mass index 22.9 [1.6] kg/m2) underwent 4 experimental days receiving 2 infusions on each day: either CCK (0.4 pmol × kg−1 × min−1, time 0-180 minutes) + GLP-2 (10 pmol × kg−1 × min−1, time 30-240 minutes), CCK + placebo, placebo + GLP-2, or placebo + placebo, respectively. Gallbladder volume was measured at baseline and throughout the 4-hour study day using ultrasonography.
Results
Compared to placebo + placebo, GLP-2 + placebo did not affect gallbladder volume, but when infused in combination with CCK, GLP-2 completely abolished the strong gallbladder-contracting effect seen during CCK + placebo infusion, restoring baseline levels of gallbladder volume.
Conclusion
Exogenous GLP-2 counteracts exogenous CCK-induced gallbladder emptying in healthy men, pointing to a possible therapeutic potential for GLP-2 as a relaxing modulator of gallbladder smooth muscle tone (eg, as a bridge to surgery in biliary colic). The effect may also explain the gallbladder-related adverse events reported for GLP-2 receptor agonists used in the treatment of short bowel syndrome. Clinical Trial Registration number NCT04651868
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark.
- Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
- Clinical Research, Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
ORCID-Profile: Bolette Hartmann, Anne-Marie Ellegaard, Filip K Knop
Förderung
- Hørslev-fonden
- Savværksejer Jeppe Juhl og hustru Ovita Juhls Mindelegat
- Novo Nordisk Foundation
Zitieren
APA
Lange, A. H., Hansen, N. L., Pedersen, M. G., Nerild, H. H., Rehfeld, J. F., Hartmann, B., Holst, J. J., Ellegaard, A. M., & Knop, F. K. (2024). Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae421
Vancouver
Lange AH, Hansen NL, Pedersen MG, Nerild HH, Rehfeld JF, Hartmann B, et al. Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae421
BibTeX
@article{Lange2024,
author = {Lange, Andreas H and Hansen, Nina L and Pedersen, Miriam G and Nerild, Henriette H and Rehfeld, Jens F and Hartmann, Bolette and Holst, Jens J and Ellegaard, Anne-Marie and Knop, Filip K},
title = {Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae421}
}
EUVIMED